TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function
Authors:
Open Access
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (32) , 12620-12633
Abstract
No abstract availableKeywords
Funding Information
- Amgen (Amgen Inc.) (Discovery research)
This publication has 37 references indexed in Scilit:
- OSA: a fast and accurate alignment tool for RNA-SeqBioinformatics, 2012
- CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's DiseasePLOS ONE, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- Transcriptome analysis by strand-specific sequencing of complementary DNANucleic Acids Research, 2009
- A Strand-Specific RNA–Seq Analysis of the Transcriptome of the Typhoid Bacillus Salmonella TyphiPLOS Genetics, 2009
- CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activationNature, 2009
- Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-cateninNature Immunology, 2009
- Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNSNeurobiology of Disease, 2005
- The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44European Journal of Immunology, 2003
- A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic CellsJournal of Experimental Medicine, 2001